1. Home
  2. TYRA vs HLF Comparison

TYRA vs HLF Comparison

Compare TYRA & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

SELL

Current Price

$19.70

Market Cap

1.3B

Sector

Health Care

ML Signal

SELL

Logo Herbalife Ltd.

HLF

Herbalife Ltd.

SELL

Current Price

$15.76

Market Cap

1.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TYRA
HLF
Founded
2018
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
TYRA
HLF
Price
$19.70
$15.76
Analyst Decision
Strong Buy
Buy
Analyst Count
15
4
Target Price
★ $47.45
$17.33
AVG Volume (30 Days)
577.7K
★ 1.5M
Earning Date
11-10-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.88
Revenue
N/A
★ $5,037,500,000.00
Revenue This Year
N/A
$5.28
Revenue Next Year
N/A
$1.99
P/E Ratio
★ N/A
$18.34
Revenue Growth
N/A
★ 0.89
52 Week Low
$15.94
$8.90
52 Week High
$40.65
$20.40

Technical Indicators

Market Signals
Indicator
TYRA
HLF
Relative Strength Index (RSI) 41.01 63.91
Support Level $18.46 $15.61
Resistance Level $22.69 $17.22
Average True Range (ATR) 1.19 0.69
MACD -0.10 0.11
Stochastic Oscillator 12.33 84.58

Price Performance

Historical Comparison
TYRA
HLF

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About HLF Herbalife Ltd.

Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.

Share on Social Networks: